Overview
Fellowship: Duke University, Hematology & Medical Oncology (2021-present)
Residency: University of Miami / Jackson Memorial Hospital (2018-2021)
Medical/Graduate: Medical University of South Carolina (2008-2018)
Doctor of Medicine, May 2018
Doctor of Philosophy in Microbiology & Immunology, May 2018
Undergraduate: University of South Carolina (2004-2008)
Bachelor of Science, Chemical Engineering
Bachelor of Science, Biological Sciences
Minor in Medical Humanities
Residency: University of Miami / Jackson Memorial Hospital (2018-2021)
Medical/Graduate: Medical University of South Carolina (2008-2018)
Doctor of Medicine, May 2018
Doctor of Philosophy in Microbiology & Immunology, May 2018
Undergraduate: University of South Carolina (2004-2008)
Bachelor of Science, Chemical Engineering
Bachelor of Science, Biological Sciences
Minor in Medical Humanities
Current Appointments & Affiliations
Medical Instructor in the Department of Medicine
·
2025 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2025 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
Journal Article Prostate Cancer Prostatic Dis · March 2025 BACKGROUND: Refinement of the risk classification for localized prostate cancer is warranted to aid in clinical decision making. A systematic analysis was undertaken to evaluate the prognostic ability of three genomic classifiers, Decipher, GPS, and Prolar ... Full text Link to item CiteHeightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Journal Article Blood Adv · February 13, 2024 Chronic graft-versus-host disease (cGVHD) is a debilitating, autoimmune-like syndrome that can occur after allogeneic hematopoietic stem cell transplantation. Constitutively activated B cells contribute to ongoing alloreactivity and autoreactivity in patie ... Full text Open Access Link to item CiteThe DNA Sensor AIM2 Determines B Cell Fate after BCR Activation in Chronic Graft-Vs-Host Disease
Conference Blood · November 2, 2023 Prevention and treatment of chronic graft-vs-host disease (cGVHD), a debilitating late immune toxicity in patients after allogeneic hematopoietic stem cell transplantation (allo-HCT), who are otherwise cured of hematolo ... Full text CiteRecent Grants
The Role of the DNA Sensor AIM2 in B Cell Fate and Function After HCT
ResearchPI-Fellow · Awarded by Leukemia & Lymphoma Society · 2024 - 2026View All Grants
Education, Training & Certifications
Medical University of South Carolina ·
2018
M.D.
University of South Carolina, Columbia ·
2008
B.S.